Condensed Consolidated Statement of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Cash flows from operating activities
Net loss	$ (5,891)	$ (1,360)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation	99	6
Amortization of intangible assets	42	57
Stock–based expense	1,299	40
Loss on sale of investments	84	731
Impairment – equity method investment, related party	2,500
Impairment of long–term investments	287
Accretion of debt discount	37
Change in operating assets and liabilities
Prepaid expenses and other current assets	33	58
Accounts payable	263	59
Accrued expenses	72	22
Digital currencies	(9)
Other payables	5	11
Net cash used in operating activities	(1,180)	(376)
Cash flows from investing activities
Release of restricted cash		39
Purchase of note receivable– long term		(30)
Proceeds from sale of investments	26	197
Net cash provided by investing activities	26	206
Cash flows from financing activities
Proceeds on issuance of convertible notes	600
Issuance costs paid on convertible notes	(107)
Proceeds from private placement	650
Proceeds from issuance of note payable
Net cash provided by financing activities	1,143
Net change in cash and cash equivalents	(11)	(170)
Cash and cash equivalents, beginning of period	345	359
Cash and cash equivalents, end of period	334	189
Supplemental disclosures of cash flow information
Cash paid for interest	7
Cash paid for taxes
Supplemental non–cash disclosures (investing and financing activities)
Settlement of note receivable for FNCX Common stock		825
Settlement of note receivable for FNCX Preferred Series D stock		110
Beneficial conversion feature on convertible debt and warrants issued concurrent with debt	279
Conversion of convertible debt	1,800
Issuance of commitment note as a deferred offering cost	160
Reclassification adjustment upon sale of available for sale investments into net loss	66	678
Unrealized loss on available for sale investments		$ (248)